Skip to main navigation Skip to search Skip to main content

Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE Studies

  • James R. Klinger
  • , Hikmet Al-Hiti
  • , Sung A. Chang
  • , Hyuk J. Chang
  • , Hossein Ardeschir Ghofrani
  • , Ekkehard Grünig
  • , Marius M. Hoeper
  • , Pavel Jansa
  • , Jaquelina Ota-Arakaki
  • , Tomas Pulido
  • , Gérald Simonneau
  • , Carmine Dario Vizza
  • , Claudia Rahner
  • , Christian Meier
  • , Gisela Meyer
  • Brown University
  • Institute for Clinical and Experimental Medicine
  • Yonsei University
  • Justus Liebig University Giessen
  • Kerckhoff Heart and Thorax Center
  • Imperial College London
  • Heidelberg University 
  • Hannover Medical School
  • Charles University
  • Universidade Federal de São Paulo
  • National Heart Institute
  • Assistance publique – Hôpitaux de Paris
  • University of Rome La Sapienza
  • Chrestos Concept GmbH & Co. KG
  • Bayer AG
  • Complexo Hospitalar da Santa Casa de Misericórdia de Porto Alegre

Research output: Contribution to journal › Article › peer-review

1   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Predicting Response to Switching From Phosphodiesterase Type 5 Inhibitor to Riociguat in Patients With Pulmonary Arterial Hypertension: Biomarker and Responder Analysis of the RESPITE and REPLACE Studies'. Together they form a unique fingerprint.
Sort by

Biochemistry, Genetics and Molecular Biology

Neuroscience